A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Capecitabine, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Capecitabine impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Capecitabine-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Capecitabine Related Compounds

Stable Isotopes

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
2’-O-(5’-Deoxy-ß-D-ribofuranosyl) Capecitabine-d11 Stable Isotopes CS-T-96600 Not Available Enquire
a-Capecitabine-d11 Stable Isotopes CS-T-96626 Not Available Enquire
Capecitabine-d11 Stable Isotopes CS-O-06460 1132662-08-8 In Stock


API

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Capecitabine API CS-O-01072 154361-50-9 In Stock
Capecitabine Hydrochloride API CS-EO-03394 1370587-15-7 Enquire
Doxifluridine API CS-O-07516 3094-09-5 In Stock


Metabolite

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
5′-Deoxy-5-fluorocytidine Metabolite CS-O-03395 66335-38-4 In Stock
β-Capecitabine Metabolite CS-O-10489 Not Available Enquire


Impurity

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentoxycarbonxyl)cyt... Impurity CS-T-52379 162204-20-8 In Stock
2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine Impurity CS-T-52017 1262133-66-3 In Stock
3’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine Impurity CS-T-52018 1262133-64-1 In Stock
3'-O-(5'-Deoxy-alpha-D-ribofuranosyl) Capecitabine Impurity CS-T-52019 1262133-68-5 In Stock
5′-Fluorodeoxyuridine Impurity CS-O-46721 38817-29-7 Enquire
5-Deoxy-5-Fluoro-N4-(methoxy carbonyl)Cytidine Impurity CS-O-57687 ---- Enquire
5-Deoxy-α-D-ribofuranose Triacetate Impurity CS-T-102282 76497-54-6 Enquire
5-Fluoro-N-[(pentyloxy)carbonyl]cytidine Impurity CS-O-48859 396684-42-7 Enquire
Capecitabine EP Impurity D Impurity CS-T-51963 910129-15-6 In Stock
Capecitabine Impurity 5 Impurity CS-EO-00021 ---- Enquire
Capecitabine-2',3'-cyclic Carbonate Impurity CS-T-50238 921769-65-5 In Stock
Methyl 2,3-O-Isopropylidene-D-Ribofuranoside Impurity CS-EM-03216 72402-14-3 In Stock
2’-O-(5’-Deoxy-alpha-D-ribofuranosyl) Capecitabine Impurity CS-O-44158 2170835-86-4 Enquire
Capecitabine Isomers Impurity CS-EO-03208 Not Available Enquire


Intermediate

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
2,3-Di-O-acetyl-5-deoxy-5-fluorocytidine Intermediate CS-T-52376 161599-46-8 In Stock


Nitrosamine

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
N-Nitroso Capecitabine Nitrosamine CS-O-57752 ---- Enquire


Secondary Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Capecitabine Impurity D(Secondary Standards traceble to EP) Secondary Standards CS-ER-02535 910129-15-6 Enquire
Capecitabine Secondary Standards CS-SS-24403-1GM 154361-50-9 Enquire
Capecitabine Related Compound A Secondary Standards CS-SS-25599-50MG 66335-38-4 Enquire


Therapeutic

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Tetrahydrouridine Therapeutic CS-O-05908 18771-50-1 In Stock


EP Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Capecitabine Impurity D (Y0001645) EP Standards CS-EG-00249 910129-15-6 Enquire